Radiant Biotherapeutics
PrivateLast Round
Series A
Sep 11, 2024
Est. Valuation
$65M
Total Funding Raised
$45.17M
Company Overview
Radiant Biotherapeutics is a biotechnology company that develops a modular multi-valent and multi-specific platform to create potent biologics for the treatment of cancer, autoimmune disorders, and infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Radiant Biotherapeutics Comparables
Compare Radiant Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tentarix Biotherapeutics | 82% | |
| Invenra | 79% | |
| EpimAb Biotherapeutics | 77% | |
Radiant Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 11, 2024 | ||||
| Grant | Dec 20, 2023 | ||||
| Seed | Apr 25, 2023 |
Key People
Founding team and executive leadership
Radiant Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aberdeen Group plc | Series A |
| Amplitude Ventures | Series A, Seed |
| Business Development Bank of Canada (BDC Capital) | Series A |
| BDC Capital | Series A |
| Gates Foundation | Series A |
| The Bill & Melinda Gates Foundation Trust | Grant, Series A |
| Alexandria Venture Investments | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 3, 2025
New data from lead oncology program to be presented at SITC 2025.
- Oct 3, 2025
Will attend and present at the SITC 2025 Annual Meeting.
Radiant Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Radiant Biotherapeutics's valuation, stock price, and market status.